EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV+ epithelial cancers
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 22 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 22 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancersmBio · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE315868_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1399456 and SRA study SRP660403. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 22 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9438433 C666-1_EBNA1_A_ChIP
- GSM9438434 C666-1_EBNA1_B_ChIP
- GSM9438435 C666-1_Input_A_ChIP
- GSM9438436 C666-1_Input_B_ChIP
- GSM9438822 C666-1, DMSO treatment 1 C666-1, DMSO treatment
- GSM9438823 C666-1, DMSO treatment 2 C666-1, DMSO treatment
- GSM9438824 C666-1, DMSO treatment 3 C666-1, DMSO treatment
- GSM9438825 C666-1, VK1727 treatment 1 C666-1, VK1727 treatment
- GSM9438826 C666-1, VK1727 treatment 2 C666-1, VK1727 treatment
- GSM9438827 C666-1, VK1727 treatment 3 C666-1, VK1727 treatment
- GSM9438828 SNU719, DMSO treatment 1 SNU719, DMSO treatment
- GSM9438829 SNU719, DMSO treatment 2 SNU719, DMSO treatment
- GSM9438830 SNU719, DMSO treatment 3 SNU719, DMSO treatment
- GSM9438831 SNU719, VK1727 treatment 1 SNU719, VK1727 treatment
- GSM9438832 SNU719, VK1727 treatment 2 SNU719, VK1727 treatment
- GSM9438833 SNU719, VK1727 treatment 3 SNU719, VK1727 treatment
- GSM9438834 PDX-C15, DMSO treatment 1 PDX-C15, DMSO treatment
- GSM9438835 PDX-C15, DMSO treatment 2 PDX-C15, DMSO treatment
- GSM9438836 PDX-C15, DMSO treatment 3 PDX-C15, DMSO treatment
- GSM9438837 PDX-C15, VK1727 treatment 1 PDX-C15, VK1727 treatme…
- GSM9438838 PDX-C15, VK1727 treatment 2 PDX-C15, VK1727 treatme…
- GSM9438839 PDX-C15, VK1727 treatment 3 PDX-C15, VK1727 treatme…
- GSE315867 EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV+ epithelial cancers [RNA-Seq] 18 samples shares pou2f1, ebna1, cdc7, ebv, inhibitors, epithelial, targets, direct
- GSE315844 EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers [ChIP-Seq] 4 samples shares pou2f1, ebna1, cdc7, ebv, inhibitors, epithelial, targets, direct
- GSE284839 USP7 inhibitors disrupt EBNA1 interactome and EBV tumorigenesis 12 samples shares ebna1, ebv, inhibitors
- GSE306456 EBNA1 SUMOylation by PIAS1 Suppresses EBV Lytic Replication and Enhances Episome Maintenance 3 samples shares ebna1, ebv
- GSE309453 EBV infection in epithelial malignancies induces resistance to the anti-tumor function of natural killer cells via CD73-mediated metabolism of AMP [NK cells] 18 samples shares ebv, epithelial
- GSE309452 EBV infection in epithelial malignancies induces resistance to the anti-tumor function of natural killer cells via CD73-mediated metabolism of AMP [cell line] 12 samples shares ebv, epithelial
- GSE240276 OLFM4 is a direct target of the cGAS-STING pathway and acts as an extracellular inhibitor for the Hippo signaling in EBV-associated cancer 12 samples shares ebv, direct
- GSE240274 OLFM4 is a direct target of the cGAS-STING pathway and acts as an extracellular inhibitor for the Hippo signaling in EBV-associated cancer 6 samples shares ebv, direct
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.